1. Home
  2. Labeler Index
  3. Cypress Pharmaceutical, Inc.
  4. NDC Product Code: 60258-005 Cytra-k Crystals

NDC 60258-005 Cytra-k Crystals

View Dosage, Usage, Ingredients, Routes, UNII

Table of Contents

  1. Product Information
  2. Product Packages
  3. Product Characteristics
  4. What is NDC 60258-005?
  5. Cytra-k Crystals Uses
  6. Active Ingredients UNII Codes
  7. Inactive Ingredients UNII Codes
  8. NDC to RxNorm Crosswalk

Product Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.
NDC Product Code:
60258-005
Proprietary Name:
Cytra-k Crystals
Product Type: [3]
INACTIVATED PRODUCT and EXCLUDED the from NDC Directory
Labeler Name: [5]
Cypress Pharmaceutical, Inc.
Labeler Code:
60258
Product Label ID:
490c77d7-47f8-439f-aa37-953692f4c23a
Start Marketing Date: [9]
05-01-2003
Listing Expiration Date: [11]
12-31-2018
Exclude Flag: [12]
I
Code Structure:
Code Navigator:

Product Characteristics

Color(s):
RED (C48326 - FD&C RED DYE #3)
Flavor(s):
FRUIT PUNCH (C73390)

Product Packages

NDC Code 60258-005-01

Package Description: 100 GRANULE, FOR SOLUTION in 1 BOX

Price per Unit: $0.51001 per EA

Product Details

What is NDC 60258-005?

The NDC code 60258-005 is assigned by the FDA to the product Cytra-k Crystals which is product labeled by Cypress Pharmaceutical, Inc.. The product's dosage form is . The product is distributed in a single package with assigned NDC code 60258-005-01 100 granule, for solution in 1 box . This page includes all the important details about this product, including active and inactive ingredients, pharmagologic classes, product uses and characteristics, UNII information and RxNorm crosswalk.

What are the uses for Cytra-k Crystals?

CYTRA-K CRYSTALS is an effective alkalinizing agent useful in those conditions where long-term maintenance of an alkaline urine is desirable, such as in patients with uric acid and cystine calculi of the urinary tract, especially when the administration of sodium salts is undesirable or contraindicated. In addition, it is a valuable adjuvant when administered with uricosuric agents in gout therapy, since urates tend to crystallize out of an acid urine. It is also effective in correcting the acidosis of certain renal tubular disorders where the administration of potassium citrate may be preferable. CYTRA-K CRYSTALS is highly concentrated, and when administered after meals and before bedtime, allows one to maintain an alkaline urinary pH around the clock, usually without the necessity of a 2 A.M. dose. CYTRA-K CRYSTALS alkalinizes the urine without producing a systemic alkalosis in recommended dosage. It is highly palatable, pleasant tasting, and tolerable, even when administered for long periods. Potassium citrate does not neutralize the gastric juice or disturb digestion.

Which are Cytra-k Crystals UNII Codes?

The UNII codes for the active ingredients in this product are:

Which are Cytra-k Crystals Inactive Ingredients UNII Codes?

The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:

What is the NDC to RxNorm Crosswalk for Cytra-k Crystals?

RxNorm is a normalized naming system for generic and branded drugs that assigns unique concept identifier(s) known as RxCUIs to NDC products.The NDC to RxNorm Crosswalk for this produdct indicates multiple concept unique identifiers (RXCUIs) are associated with this product:
  • RxCUI: 1652634 - potassium citrate 3300 MG / citric acid 1002 MG Powder for Oral Solution
  • RxCUI: 1652634 - citric acid 1002 MG / potassium citrate 3300 MG Powder for Oral Solution
  • RxCUI: 1652634 - Citric Acid 1002 MG / K+ citrate 3300 MG Powder for Oral Solution
  • RxCUI: 1652634 - Citric Acid 1002 MG / Pot citrate 3300 MG Powder for Oral Solution
  • RxCUI: 1652638 - CYTRA-K CRYSTALS 3300 MG / 1002 MG Powder for Oral Solution

* Please review the disclaimer below.

Product Footnotes

[5] What is the Labeler Name? - Name of Company corresponding to the labeler code segment of the Product NDC.

[9] What is the Start Marketing Date? - This is the date that the labeler indicates was the start of its marketing of the drug product.

[11] What is the Listing Expiration Date? - This is the date when the listing record will expire if not updated or certified by the product labeler.

[12] What is the NDC Exclude Flag? - This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions ("Y"), or because the listing certification is expired ("E"), or because the listing data was inactivated by FDA ("I"). Values = "Y", "N", "E", or "I".